Stock PRFX PAINREFORM LTD.
Add to a list
To use this feature you must be a member
Log inSign up

All News PainReform Ltd.

Equities

PRFX

IL0011651580

Market Closed - Nasdaq
Other stock markets
 04:30:00 2024-05-22 pm EDT 		5-day change 1st Jan Change
0.75 USD 0.00% Intraday chart for PainReform Ltd. -6.26% -72.73%
Apr. 16 PainReform Prices $4 Million Offering; Shares Tumble Pre-Bell MT
Apr. 09 Painreform Ltd. Announces Groundbreaking Results from New Studies Demonstrating the Superior In-Vitro Release Rates of PRF-110 CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
PAINREFORM : CONDENSED FINANCIAL STATEMENTS - Form 6-K
PU
PainReform Provides Business Update for the First Quarter of 2024
AQ
PainReform : CEO Ilan Hadar Discusses Latest Developments Related to PRF-110 and its Potential to Help Tackle the Opioid Epidemic on Proactiveinvestors.com
PU
PainReform Announces Closing of $4 Million Public Offering
AQ
PainReform Prices $4 Million Offering; Shares Tumble Pre-Bell
MT
PainReform Announces Pricing of $4 Million Public Offering
AQ
PainReform : CEO IlanHadar Interviewed on “The Big Biz Show”
PU
Painreform Ltd. Announces Groundbreaking Results from New Studies Demonstrating the Superior In-Vitro Release Rates of PRF-110
CI
PainReform : Non-Opiate Topical Treatment for Post-Surgical Pain Relief Outperforms Leading Competitor Under Various Testing Conditions
PU
PainReform Reaches 50% Enrollment in the Second Part of its Phase 3 Clinical Trial of PRF-110 in Bunionectomy
AQ
PainReform Ltd. Reaches 50% Enrollment in the Second Part of its Phase 3 Clinical Trial of PRF-110 in Bunionectomy
CI
PainReform : NOTICE OF EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS - Form 6-K
PU
PainReform : Investors Presentation – March 2024
PU
PainReform Provides Year-End Business Update
AQ
PainReform Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
PainReform to Present at the Microcap Conference in Atlantic City
NE
PainReform to Present at the Microcap Conference in Atlantic City
AQ
PainReform Reports Successful Head-to-Head Comparison of PRF-110 Versus Market Leading Post Surgical Analgesia for Extended Postoperative Pain Relief
AQ
PainReform Reports Successful Head-to-Head Comparison of PRF-110 Versus Market Leading Post Surgical Analgesia for Extended Postoperative Pain Relief
CI
PainReform Announces Exercise of Warrants for Approximately $1.3 Million in Gross Proceeds
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. PRFX Stock
  4. News PainReform Ltd.